Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).
Lim KJ, Wellard C, Talaulikar D, Tan JL, Loh J, Puvanakumar P, Kuzich JA, Ho M, Murphy M, Zeglinas N, Low MS, Routledge D, Lim AB, Gibbs SD, Quach H, Morgan S, Moore E, Ninkovic S. Lim KJ, et al. Among authors: routledge d. EJHaem. 2023 Jul 25;4(3):639-646. doi: 10.1002/jha2.742. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601874 Free PMC article.
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.
Nooka AK, Weisel K, van de Donk NW, Routledge D, Otero PR, Song K, Quach H, Callander N, Minnema MC, Trudel S, Jackson NA, Ahlers CM, Im E, Cheng S, Smith L, Hareth N, Ferron-Brady G, Brouch M, Montes de Oca R, Paul S, Holkova B, Gupta I, Kremer BE, Richardson P. Nooka AK, et al. Among authors: routledge d. Future Oncol. 2021 Jun;17(16):1987-2003. doi: 10.2217/fon-2020-1269. Epub 2021 Mar 8. Future Oncol. 2021. PMID: 33682447 Free article.
The development of a home-based therapeutic platform for multiple myeloma.
Beer H, Routledge D, Joyce T, Furphy EJ, Combe N, Ritchie D, Khot A, Lim SM, Montalto M, Harrison SJ. Beer H, et al. Among authors: routledge d. Expert Rev Hematol. 2021 Dec;14(12):1129-1135. doi: 10.1080/17474086.2021.2022471. Epub 2022 Jan 7. Expert Rev Hematol. 2021. PMID: 34936527
Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021.
Fernando SS, Paige EK, Dendle C, Weinkove R, Kong DCM, Omond P, Routledge DJ, Szer J, Blyth CC; Australasian Antifungal Guidelines Steering Committee. Fernando SS, et al. Among authors: routledge dj. Intern Med J. 2021 Nov;51 Suppl 7:220-233. doi: 10.1111/imj.15593. Intern Med J. 2021. PMID: 34937138
Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant.
Shipton MJ, Kinsella PM, Davis T, Azzato F, Taiaroa G, Szer J, Routledge D, Smibert O. Shipton MJ, et al. Among authors: routledge d. Bone Marrow Transplant. 2022 Jun;57(6):1028-1030. doi: 10.1038/s41409-022-01669-8. Epub 2022 Apr 11. Bone Marrow Transplant. 2022. PMID: 35411105 Free PMC article. No abstract available.
VEXAS syndrome: A dermatological perspective.
Nguyen JK, Routledge D, van Der Weyden C, Blombery P, Angel CM, Johnson D, Goh MS, Lee A. Nguyen JK, et al. Among authors: routledge d. Australas J Dermatol. 2022 Nov;63(4):488-492. doi: 10.1111/ajd.13932. Epub 2022 Oct 5. Australas J Dermatol. 2022. PMID: 36197697
30 results